These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15270757)

  • 1. Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis.
    Ijiri Y; Inoue T; Fukuda F; Suzuki K; Kobayashi T; Shibahara N; Takenaka H; Tanaka K
    Epilepsia; 2004 Aug; 45(8):924-7. PubMed ID: 15270757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide: a new antiepileptic drug.
    Oommen KJ; Mathews S
    Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide concentrations during pregnancy.
    Oles KS; Bell WL
    Ann Pharmacother; 2008 Jul; 42(7):1139-41. PubMed ID: 18577760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies.
    Miura H
    Seizure; 2004 Dec; 13 Suppl 1():S17-23; discussion S24-5. PubMed ID: 15511682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model.
    Borowicz KK; Luszczki JJ; Sobieszek G; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between convulsive seizures and serum and brain concentrations of phenobarbital and zonisamide in mutant inbred strain EL mouse.
    Nagatomo I; Akasaki Y; Nagase F; Nomaguchi M; Takigawa M
    Brain Res; 1996 Aug; 731(1-2):190-8. PubMed ID: 8883869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy.
    Joo EY; Kim SH; Seo DW; Hong SB
    Clin Neurophysiol; 2008 Jun; 119(6):1385-92. PubMed ID: 18396455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
    Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide for refractory juvenile absence epilepsy.
    Velizarova R; Crespel A; Genton P; Serafini A; Gelisse P
    Epilepsy Res; 2014 Sep; 108(7):1263-6. PubMed ID: 24907183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of gabapentin in anuric subjects on hemodialysis.
    Wong MO; Eldon MA; Keane WF; Türck D; Bockbrader HN; Underwood BA; Sedman AJ; Halstenson CE
    J Clin Pharmacol; 1995 Jun; 35(6):622-6. PubMed ID: 7665723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.